In Vitro Blood-Brain Barrier Modeling adapted for Peripheral Blood Mononuclear Cell Transmigration from HIV-Positive Patients for Clinical Research on Therapeutic Drug Intervention

被引:0
|
作者
Oda, Robert [1 ]
Shiramizu, Bruce [2 ]
Agsalda-Garcia, Melissa [2 ]
Kettlewell, Joanna [2 ]
Wojna, Valerie [3 ]
机构
[1] Univ Hawaii Manoa, Coll Trop Agr & Human Resources, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA
[2] Univ Hawaii, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI USA
[3] Univ Puerto Rico, Neurol Div, Dept Med, Med Sci Campus, San Juan, PR 00936 USA
关键词
HIV; Cognition; Blood-brain barrier; Neurocognition; Brain; MONOCYTES; DNA; DEMENTIA; HAART;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: HIV-associated cognitive impairment (HACI) continues to persist for HIV-seropositive individuals who are on antiretroviral therapy (ART). HACI develops in part when HIV-infected monocytes (MOs) transmigrate through the blood-brain barrier (BBB) and secrete pro-inflammatory cytokines and chemokines, which leads to neuronal damage. In vitro BBB models are important tools that can elucidate mechanisms of MO transmigration. Previously described in vitro BBB models relied on pathology specimens, resulting in potentially variable and inconsistent results. This project reports on a reliable and consistent alternative in vitro BBB model that has the potential to be used in clinical research intervention studies analyzing the effects of ART on the BBB and on MO transmigration. Methods: A bilayer BBB model was established with commercially available astrocytes and endothelial cells on a 3 mu m PET membrane insert to allow the contact of astrocytic foot processes with endothelial cells. Inserts were cultured in growth medium for 7 days before exposure to HIV- or HIV+ peripheral blood mononuclear cells (PBMCs). PBMCs were allowed to transmigrate across the BBB for 24 hours. Results: Confluency and integrity measurements by trans-endothelial electrical resistance (TEER) (136.7 +/- 18.3 Omega/cm(2)) and permeability (5.64 +/- 2.20%) verified the integrity of the in vitro BBB model. Transmigrated MOs and non-MOs were collected and counted (6.0x10(4) MOs; 1.1x10(5) non-MOs). Markers indicative of glial fibrillary acidic protein (GFAP), von Willebrand factor (vWF), and p-glycoprotein (Pgp) were revealed in immunofluorescence staining (IF), indicating BBB phenotype and functionality. Conclusion: Potential applications for this model include assessing the HIV DNA copy numbers of transmigrated cells (pre- and post-targeted ART) and understanding the role of oxidative stress related to HIV DNA and HACI.
引用
收藏
页码:155 / 159
页数:5
相关论文
共 50 条
  • [41] Brain penetration predictivity using in-vitro primary rat and human cell-based blood-brain barrier models for drug discovery and development
    Lacombe, O.
    Guyol, A. C.
    Videau, O.
    Pruvost, A.
    Bolze, S.
    Prevost, C.
    Mabondzo, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 8 - 8
  • [42] FOXP3 mRNA levels are decreased in peripheral blood CD4+ lymphocytes from HIV-positive patients
    Apoil, PA
    Puissant, B
    Roubinet, F
    Abbal, M
    Massip, P
    Blancher, A
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (04) : 381 - 385
  • [43] Modeling and rescue of defective blood-brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients
    Lee, Catherine A. A.
    Seo, Hannah S.
    Armien, Anibal G.
    Bates, Frank S.
    Tolar, Jakub
    Azarin, Samira M.
    FLUIDS AND BARRIERS OF THE CNS, 2018, 15
  • [44] Isolating peripheral blood mononuclear cells from HIV-infected patients for single-cell RNA sequencing and
    Jia, Jie
    Zhao, Yu
    Wang, Jian-Hua
    Kuang, Yi-Qun
    STAR PROTOCOLS, 2023, 4 (02):
  • [45] In vitro blood-brain barrier models for drug research: state-of-the-art and new perspectives on reconstituting these models on artificial basement membrane platforms
    Banerjee, Jayati
    Shi, Yejiao
    Azevedo, Helena S.
    DRUG DISCOVERY TODAY, 2016, 21 (09) : 1367 - 1386
  • [46] Establishment of an astrocyte-like cell line from the brain of tilapia (Oreochromis niloticus) for virus pathogenesis and a vitro model of the blood-brain barrier
    Li, Yuan
    Huang, Yu
    Cai, Jia
    Jiang, Dongneng
    Jian, Ji-chang
    Lu, Yi-shan
    Wang, Bei
    JOURNAL OF FISH DISEASES, 2022, 45 (10) : 1451 - 1462
  • [47] Serum from Interferon-β-1b Treated MS Patients Induced In Vitro Stabilisation of the Blood-Brain Barrier
    Mueller, Marcus
    Frese, Achim
    Nassenstein, Isabelle
    Hoppen, Maike
    Marziniak, Martin
    Ringelstein, E. Bernd
    Kim, Kwang S.
    Schaebitz, Wolf
    Kraus, Joerg
    NEUROLOGY, 2010, 74 (09) : A417 - A417
  • [48] Serum antibodies from patients with neuropsychiatric systemic lupus erythematosus cause activation and damage to an in vitro blood-brain barrier model
    Mendonca, LLF
    Smith, R
    Hughes, GRV
    Dolman, DEM
    Dobbie, M
    Hurst, RD
    Abbott, NJ
    JOURNAL OF PHYSIOLOGY-LONDON, 2000, 525 : 38P - 38P
  • [49] Prediction of Drug Permeability Using In Vitro Blood-Brain Barrier Models with Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells
    Ohshima, Makiko
    Kamei, Shota
    Fushimi, Hideo
    Mima, Shinji
    Yamada, Tadanori
    Yamamoto, Takeshi
    BIORESEARCH OPEN ACCESS, 2019, 8 (01): : 200 - 209
  • [50] Single-Cell Microwell Platform Reveals Circulating Neural Cells as a Clinical Indicator for Patients with Blood-Brain Barrier Breakdown
    Zhang, Yu
    Warden, Antony R.
    Ahmad, Khan Zara
    Liu, Yanlei
    He, Xijun
    Zheng, Minqiao
    Huo, Xinlong
    Zhi, Xiao
    Ke, Yuqing
    Li, Hongxia
    Yan, Sijia
    Su, Wenqiong
    Cai, Deng
    Ding, Xianting
    RESEARCH, 2021, 2021